Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D Bernstein

Showing results (91-100 of 126) with videos related to

Pageof 13
Sort By:
Blood|April 1, 1992
Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemiaI D Bernstein, J W Singer, F O Smith, et al.
Medical and Pediatric Oncology|January 1, 1989
Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: a report from the Childrens Cancer Study GroupJ D Buckley, B C Lampkin, M E Nesbit, et al.
The Journal of Clinical Investigation|April 1, 1987
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressedI D Bernstein, J W Singer, R G Andrews, et al.
Blood|May 9, 2001
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cellsV H van Der Velden, J G te Marvelde, P G Hoogeveen, et al.
Blood|May 1, 1992
Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significanceF O Smith, B C Lampkin, C Versteeg, et al.
Blood|October 15, 1991
Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primatesR G Andrews, G H Knitter, S H Bartelmez, et al.
Medical and Pediatric Oncology|January 1, 1992
Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study GroupP A Dinndorf, J D Buckley, M E Nesbit, et al.
Blood|May 26, 1999
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugateE L Sievers, F R Appelbaum, R T Spielberger, et al.
Blood|July 1, 1989
Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsivenessL S Park, P E Waldron, D Friend, et al.
Cancer Research|January 1, 1992
Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor modelR H van der Jagt, C C Badger, F R Appelbaum, et al.
Pageof 13

Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Blood|April 1, 1992
Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemiaI D Bernstein, J W Singer, F O Smith, et al.
Medical and Pediatric Oncology|January 1, 1989
Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: a report from the Childrens Cancer Study GroupJ D Buckley, B C Lampkin, M E Nesbit, et al.
The Journal of Clinical Investigation|April 1, 1987
Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressedI D Bernstein, J W Singer, R G Andrews, et al.
Blood|May 9, 2001
Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cellsV H van Der Velden, J G te Marvelde, P G Hoogeveen, et al.
Blood|May 1, 1992
Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significanceF O Smith, B C Lampkin, C Versteeg, et al.
Blood|October 15, 1991
Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primatesR G Andrews, G H Knitter, S H Bartelmez, et al.
Medical and Pediatric Oncology|January 1, 1992
Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study GroupP A Dinndorf, J D Buckley, M E Nesbit, et al.
Blood|May 26, 1999
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugateE L Sievers, F R Appelbaum, R T Spielberger, et al.
Blood|July 1, 1989
Interleukin-3, GM-CSF, and G-CSF receptor expression on cell lines and primary leukemia cells: receptor heterogeneity and relationship to growth factor responsivenessL S Park, P E Waldron, D Friend, et al.
Cancer Research|January 1, 1992
Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor modelR H van der Jagt, C C Badger, F R Appelbaum, et al.
Pageof 13